"Parkinson Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Descriptor ID |
D010300
|
| MeSH Number(s) |
C10.228.140.079.862.500 C10.228.662.600.400 C10.574.812
|
| Concept/Terms |
Parkinson Disease- Parkinson Disease
- Idiopathic Parkinson's Disease
- Lewy Body Parkinson Disease
- Lewy Body Parkinson's Disease
- Primary Parkinsonism
- Parkinsonism, Primary
- Parkinson Disease, Idiopathic
- Parkinson's Disease
- Parkinson's Disease, Idiopathic
- Parkinson's Disease, Lewy Body
- Idiopathic Parkinson Disease
- Paralysis Agitans
|
Below are MeSH descriptors whose meaning is more general than "Parkinson Disease".
Below are MeSH descriptors whose meaning is more specific than "Parkinson Disease".
This graph shows the total number of publications written about "Parkinson Disease" by people in this website by year, and whether "Parkinson Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 3 | 0 | 3 |
| 1998 | 3 | 0 | 3 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 0 | 2 |
| 2002 | 4 | 1 | 5 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 3 | 4 |
| 2006 | 5 | 1 | 6 |
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 0 | 2 |
| 2010 | 5 | 1 | 6 |
| 2011 | 4 | 2 | 6 |
| 2012 | 4 | 0 | 4 |
| 2013 | 4 | 0 | 4 |
| 2014 | 6 | 1 | 7 |
| 2015 | 5 | 1 | 6 |
| 2016 | 5 | 0 | 5 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 0 | 3 |
| 2019 | 7 | 1 | 8 |
| 2020 | 4 | 0 | 4 |
| 2021 | 6 | 0 | 6 |
| 2022 | 6 | 0 | 6 |
| 2023 | 11 | 0 | 11 |
| 2024 | 8 | 1 | 9 |
| 2025 | 6 | 0 | 6 |
| 2026 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
Safety and efficacy of staged, bilateral magnetic resonance-guided focused ultrasound pallidothalamic tractotomy for motor complications of Parkinson's disease: a prospective, multicentre, single-arm trial. Lancet Neurol. 2026 Jul; 25(7):654-663.
-
Practical approaches to inclusive recruitment practices in Parkinson's disease research. J Parkinsons Dis. 2026 Jun; 16(4):709-722.
-
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations. Brain. 2026 May 05; 149(5):1537-1553.
-
A 360 Degree Qualitative Ethical Assessment of Reporting Patient Reported Outcomes. J Empir Res Hum Res Ethics. 2026 Jul; 21(3):220-232.
-
Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's disease. Parkinsonism Relat Disord. 2025 Nov; 140:108057.
-
Bedside Assessment of Downgaze Limit by Amplitude. Mov Disord Clin Pract. 2025 Dec; 12(12):2224-2231.
-
Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patients. Parkinsonism Relat Disord. 2025 Sep; 138:107951.
-
Reduced DJ-1-F1Fo ATP synthase association correlates with midbrain dopaminergic neuron vulnerability in idiopathic Parkinson's disease. Sci Adv. 2025 Jun 06; 11(23):eads3051.
-
Automated Imaging Differentiation for Parkinsonism. JAMA Neurol. 2025 May 01; 82(5):495-505.
-
Role of substantia Nigra dopaminergic neurons in respiratory modulation and limitations of levodopa in Parkinson's disease. Exp Neurol. 2025 May; 387:115193.